{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:25:58Z","timestamp":1794119158317,"version":"4.8.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre"},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["10.54499\/2020.07131.BD"],"award-info":[{"award-number":["10.54499\/2020.07131.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018817","name":"LUPUS UK","doi-asserted-by":"publisher","award":["1543411"],"award-info":[{"award-number":["1543411"]}],"id":[{"id":"10.13039\/501100018817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To compare proliferative (PLN) and membranous (MLN) lupus nephritis (LN) regarding clinical and laboratory presentation and long-term outcomes, and to investigate predictors of progression to chronic kidney disease (CKD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Multicentre observational study, with retrospective analysis of a prospective cohort, using data from the Rheumatic Diseases Portuguese Registry \u2013 Reuma.pt. Patients with biopsy-proven PLN, MLN and mixed LN were included. Cox regression survival analysis was used to investigate predictors of CKD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 260 patients were included. Median follow-up was 8\u2009years (IQR 11; minimum 1, maximum 35\u2009years). MLN patients presented with significantly lower serum creatinine [0.70 (IQR 0.20; minimum 0.50, maximum 1.30) mg\/dl vs 0.80 (IQR 0.31; minimum 0.26, maximum 2.60) in PLN, P\u2009=\u20090.003]. Proteinuria levels did not differ between groups (P\u2009=\u20090.641). Levels of complement were reduced in PLN but nearly normal in MLN patients, and there were fewer patients with positive anti-dsDNA antibodies in the MLN group (P\u2009&amp;lt;\u20090.001). One year after the beginning of treatment, 62% of the patients achieved EULAR\/ERA-EDTA complete response, with a further 5% achieving partial response. Patients with lower proteinuria at diagnosis were more likely to achieve a complete renal response at one year; however, proteinuria at diagnosis or at one year did not predict long-term CKD. Estimated glomerular filtration rate (eGFR) \u226475\u2009mL\/min\/1.73\u00a0m2 at one year was the strongest predictor of progression to CKD (HR 23 [95% CI 8\u201362], P\u2009&amp;lt;\u20090.001). Other possible predictors included the use of azathioprine for induction of remission, older age at diagnosis and male sex.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Proteinuria levels did not predict LN histologic class in our cohort. eGFR cutoff of 75\u2009mL\/min\/1.73\u00a0m2 after one year of treatment was strongly predictive of progression to CKD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae236","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T22:21:40Z","timestamp":1713824500000},"page":"1201-1209","source":"Crossref","is-referenced-by-count":19,"title":["Risk of chronic kidney disease in 260 patients with lupus nephritis: analysis of a nationwide multicentre cohort with up to 35 years of follow-up"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1517-4383","authenticated-orcid":false,"given":"Filipa","family":"Farinha","sequence":"first","affiliation":[{"name":"Centre for Rheumatology, University College of London , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Barreira","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Centro Hospitalar e Universit\u00e1rio de Lisboa Norte, Centro Acad\u00e9mico de Medicina de Lisboa , Lisboa,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Couto","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centro Hospitalar Tondela-Viseu , Viseu,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Cunha","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Garcia de Orta , Almada,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centro Hospitalar de Vila Nova de Gaia\/Espinho, Vila Nova de Gaia ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Freitas","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Garcia de Orta , Almada,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3172-3570","authenticated-orcid":false,"given":"Lu\u00eds","family":"In\u00eas","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centro Hospitalar e Universit\u00e1rio de Coimbra , Coimbra,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9581-7088","authenticated-orcid":false,"given":"Mariana","family":"Lu\u00eds","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centro Hospitalar e Universit\u00e1rio de Coimbra , Coimbra,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Macieira","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Centro Hospitalar e Universit\u00e1rio de Lisboa Norte, Centro Acad\u00e9mico de Medicina de Lisboa , Lisboa,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9432-2216","authenticated-orcid":false,"given":"Ana R","family":"Prata","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centro Hospitalar e Universit\u00e1rio de Coimbra , Coimbra,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Reumatologia, Unidade Local de Sa\u00fade do Alto Minho , Ponte de Lima,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Santos","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centro Hospitalar do Baixo Vouga, EPE , Aveiro, Aveiro,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Torres","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Reumatologia, Centro Hospitalar Lisboa Ocidental\u2014Hospital Egas Moniz , Lisboa,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth J","family":"Pepper","sequence":"additional","affiliation":[{"name":"Centre for Nephrology, University College London , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2346-4484","authenticated-orcid":false,"given":"Anisur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, University College of London , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-1365","authenticated-orcid":false,"given":"Maria J","family":"Santos","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Garcia de Orta , Almada,","place":["Portugal"]},{"name":"Unidade de Investiga\u00e7\u00e3o em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Acad\u00e9mico de Medicina de Lisboa , Lisboa,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"2025030500182865400_keae236-B1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2025030500182865400_keae236-B2","author":"Maningding","year":"2019"},{"key":"2025030500182865400_keae236-B3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0961203309358187","article-title":"Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions","volume":"19","author":"Ortega","year":"2010","journal-title":"Lupus"},{"key":"2025030500182865400_keae236-B4","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/rheumatology\/keaa491","article-title":"Assessing outcomes in a lupus nephritis cohort over a 40-year period","volume":"60","author":"Gisca","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025030500182865400_keae236-B5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/rheumatology\/keac218","article-title":"Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40-years of follow-up","volume":"62","author":"Luo","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025030500182865400_keae236-B6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and bayesian meta-analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025030500182865400_keae236-B7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2025030500182865400_keae236-B8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"2025030500182865400_keae236-B9","first-page":"169","volume-title":"Lupus nephritis","author":"Austin","year":"2011","edition":"second ed"},{"key":"2025030500182865400_keae236-B10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10157-022-02232-x","article-title":"A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan","volume":"26","author":"Ikeuchi","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"2025030500182865400_keae236-B11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-018-1576-1","article-title":"Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV","volume":"20","author":"Hanaoka","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2025030500182865400_keae236-B12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.39026","article-title":"Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort","volume":"67","author":"Dall\u2019Era","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025030500182865400_keae236-B13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203315595130","article-title":"Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis","volume":"25","author":"Koo","year":"2016","journal-title":"Lupus"},{"key":"2025030500182865400_keae236-B14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.reuma.2017.04.005","article-title":"Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature","volume":"15","author":"Silva-Fernandez","year":"2019","journal-title":"Reumatol Clin"},{"key":"2025030500182865400_keae236-B15","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s10067-016-3366-y","article-title":"Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population","volume":"35","author":"Mejia-Vilet","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2025030500182865400_keae236-B16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4067\/S0034-98872005000100004","article-title":"Curso cl\u00ednico de la nefropat\u00eda membranosa l\u00fapica pura","volume":"133","author":"Past\u00e9n","year":"2005","journal-title":"Revista m\u00e9dica de Chile"},{"key":"2025030500182865400_keae236-B17","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3109\/14397595.2016.1158896","article-title":"Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III\/IV + V): a long-term observational study","volume":"26","author":"Ikeuchi","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2025030500182865400_keae236-B18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.semarthrit.2011.08.002","article-title":"Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients","volume":"41","author":"Moroni","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"2025030500182865400_keae236-B19","doi-asserted-by":"crossref","first-page":"e0157485","DOI":"10.1371\/journal.pone.0157485","article-title":"Comparison of outcomes between individuals with pure and mixed lupus nephritis: a retrospective study","volume":"11","author":"Ilori","year":"2016","journal-title":"PLoS One"},{"key":"2025030500182865400_keae236-B20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/09612033221088437","article-title":"Clinical characteristics and long-term outcomes in patients with mixed Class III\/IV + V and pure proliferative lupus nephritis: a single-center experience","volume":"31","author":"Ahn","year":"2022","journal-title":"Lupus"},{"key":"2025030500182865400_keae236-B21","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/rheumatology\/keaa103","article-title":"Outcomes of membranous and proliferative lupus nephritis\u2014analysis of a single-centre cohort with more than 30 years of follow-up","volume":"59","author":"Farinha","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025030500182865400_keae236-B22","first-page":"232","article-title":"Reuma.pt contribution to the knowledge of immune-mediated systemic rheumatic diseases","volume":"42","author":"Santos","year":"2017","journal-title":"Acta Reumatol Port"},{"key":"2025030500182865400_keae236-B23","first-page":"45","article-title":"Reuma.pt\u2014the rheumatic diseases portuguese register","volume":"36","author":"Canh\u00e3o","year":"2011","journal-title":"Acta Reumatol Port"},{"key":"2025030500182865400_keae236-B24","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025030500182865400_keae236-B25","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025030500182865400_keae236-B26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the Joint European League Against Rheumatism and European Renal Association\u2013European Dialysis and Transplant Association (EULAR\/ERA\u2013EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025030500182865400_keae236-B27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2025030500182865400_keae236-B28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0961203309346505","article-title":"SLEDAI-2K for a 30-day window","volume":"19","author":"Touma","year":"2010","journal-title":"Lupus"},{"key":"2025030500182865400_keae236-B29","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/1756-185X.14228","article-title":"Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis","volume":"24","author":"Suzuki","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2025030500182865400_keae236-B30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s42358-019-0105-5","article-title":"Comparison of lupus patients with early and late onset nephritis: a study in 71 patients from a single referral center","volume":"60","author":"Delfino","year":"2020","journal-title":"Adv Rheumatol"},{"key":"2025030500182865400_keae236-B31","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3349\/ymj.2020.61.11.951","article-title":"Worse renal presentation and prognosis in initial-onset lupus nephritis than early-onset lupus nephritis","volume":"61","author":"Kwon","year":"2020","journal-title":"Yonsei Med J"},{"key":"2025030500182865400_keae236-B32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12882-020-01915-5","article-title":"Comparison of clinical features and outcomes between patients with early and delayed lupus nephritis","volume":"21","author":"Ahn","year":"2020","journal-title":"BMC Nephrol"},{"key":"2025030500182865400_keae236-B33","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/annrheumdis-2020-216965","article-title":"Lack of EULAR\/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis","volume":"79","author":"Moroni","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025030500182865400_keae236-B34","doi-asserted-by":"crossref","first-page":"e000123","DOI":"10.1136\/lupus-2015-000123","article-title":"A proteinuria cut-off level of 0.7 g\/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial","volume":"2","author":"Tamirou","year":"2015","journal-title":"Lupus Sci Med"},{"key":"2025030500182865400_keae236-B35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.kint.2018.05.021","article-title":"A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy","volume":"94","author":"De Rosa","year":"2018","journal-title":"Kidney Int"},{"key":"2025030500182865400_keae236-B36","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/ndt\/gfv296","article-title":"Histologic versus clinical remission in proliferative lupus nephritis","volume":"32","author":"Malvar","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2025030500182865400_keae236-B37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000452229","article-title":"Repeated renal biopsy\u2014a predictive tool to assess the probability of renal flare in lupus nephritis","volume":"44","author":"Pi\u00f1eiro","year":"2016","journal-title":"Am J Nephrol"},{"key":"2025030500182865400_keae236-B38","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1136\/lupus-2014-000018","article-title":"Role of early repeated renal biopsies in lupus nephritis","volume":"1","author":"Zickert","year":"2014","journal-title":"Lupus Sci Med"},{"key":"2025030500182865400_keae236-B39","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000684","article-title":"One-third of patients with lupus nephritis classified as complete responders continue to accrue progressive renal damage despite resolution of proteinuria","volume":"9","author":"Weeding","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2025030500182865400_keae236-B40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.05.017","article-title":"A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis","volume":"90","author":"Anders","year":"2016","journal-title":"Kidney Int"},{"key":"2025030500182865400_keae236-B41","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/annrheumdis-2022-222512","article-title":"SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection","volume":"81","author":"Morales","year":"2022","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae236\/57666292\/keae236.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1201\/57666292\/keae236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1201\/57666292\/keae236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:21:10Z","timestamp":1741134070000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/3\/1201\/7656363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,22]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae236","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,4,22]]}}}